Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study

NCT00530504 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT00530504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2007
Completion date
January 31, 2014
Enrollment
1,500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery disease